Galmed Pharmaceuticals (GLMD) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

GLMD is expected to report earnings to rise 18.52% to -31 cents per share on March 14

Galmed Pharmaceuticals GLMD Stock Earnings Reports

Q4'23

Est.

$-0.32

Q3'23

Beat

by $0.03

Q2'23

Est.

$-0.34

Q1'23

Beat

by $0.41

Q4'22

Missed

by $1.36

The last earnings report on November 06 showed earnings per share of -27 cents, beating the estimate of -30 cents. With 231.76K shares outstanding, the current market capitalization sits at 10.68M.

View a ticker or compare two or three

Compare

GLMD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GLMD
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

16 Tiomkin Street

Phone

+972 36938448

Employees

Web

https://www.galmedpharma.com